The outlook on FDA approved new drug called Aducanumab for the treatment of Alzheimer’s disease. It is a monoclonal antibody target the basic pathology cause for Alzheimer’s disease Aducanumab is a new drug
New Dehi: On this World Alzheimer’s Day, DocsApp- a 24*7 online doctor consultation platform, has launched their latest campaign #ErasedPages to spread awareness about Alzheimer’s. A brain disorder can be
